top of page
Biomarker-research-for-web-1.png

Current Clinical Trials

APOL-1 Mediated Kidney Disease

Phase 2/​3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

​

​

​

IgA Nephropathy
 

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)​​​​​

​

​​​

​

​

Lupus Nephritis
 

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
​

​​​

​

​

Lupus Nephritis
 

A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN)

​

​

​

Lupus Nephritis
 

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

​

​

IC-MPGN
 

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN (APPARENT)

​

​

​

​

​

IgA Nephropathy
 

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients (APPLAUSE-IgAN)

​

​

​

​

To find additional clinical Trial Opportunities, visit enrollmypatient.org

Help HOPE find OPPORTUNITY™

bottom of page